Group 1 | Group 2 | p-value | |
---|---|---|---|
Age (years) | 67 ± 9 | 68 ± 9 | ns |
Hypertension (%) | 85 | 73 | ns |
IVS thickness (mm) | 11.6 ± .6 | 9.8 ± .3 | <0.01 |
PW thickness (mm) | 9.8 ± .6 | 8.7 ± .1 | ns |
Septal hypertrophy (%) | 71 | 7 | <0.01 |
BPs basal (mmHg) | 131 ± 29 | 129 ± 27 | ns |
BPd basal (mmHg) | 74 ± 10 | 69 ± 14 | ns |
HR basal (b/min) | 70 ± 8 | 66 ± 12 | ns |
HR dobutamine (b/min) | 101 ± 18 | 108 ± 18 | ns |
LVEDV basal (ml) | 99 ± 29 | 99 ± 28 | ns |
LVEDV dobutamine (ml) | 81 ± 29 | 72 ± 32 | ns |
LVESV basal (ml) | 44 ± 19 | 48 ± 14 | ns |
LVESV dobutamine (ml) | 34 ± 23 | 40 ± 24 | ns |
LVEF basal (%) | 54 ± 5 | 48 ± 14 | ns |
LVEF dobutamine (%) | 61 ± 16 | 67 ± 7 | ns |
WMSI basal | 1.44 ± .4 | 1.29 ± .4 | ns |
WMSI dobutamine | 1.62 ± .4 | 1.08 ± .4 | <0.01 |